GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Clinical trial NCT04977453 · RECRUITING

Trial details

NCT number: NCT04977453
Sponsor: GI Innovation, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Cervical Cancer Urothelial Carcinoma Clear Cell Renal Cell Cancer (ccRCC)Squamous Cell Non Small Cell Lung Cancer

Start date: 2021-08-02
Primary completion: 2028-06-30
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.